New mutations in iPS cells are mainly concentrated in non-transcriptional regions October 15, 2017 · by Aviatior · in Biotechnology industry, iPS Cells, Personalized Therapies, Regenerative Medicine. · https://www.sciencedaily.com/releases/2017/10/171010132135.htm Share this:Share on TumblrTweetWhatsAppTelegramEmailPrintRedditPocketLike Loading... Related